We are Prevacus, a start up drug development company. Prevacus is commercializing and developing a ground-breaking proprietary formalization, Prevasol, which can successfully treat and prevent the effects of a mild traumatic brain injury (mTBI-concussion).
View Top Employees from Prevacus, Inc.Website | http://www.prevacus.com |
Revenue | $2 million |
Employees | 4 (4 on RocketReach) |
Founded | 2012 |
Address | 1400 Village Square Blvd, Ste 3 414, Tallahassee, Florida 32312, US |
Phone | (850) 688-6610 |
Technologies |
JavaScript,
HTML,
G Suite
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Pharmaceutical, Health Care, Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Prevacus, Inc. employee's phone or email?
The Prevacus, Inc. annual revenue was $2 million in 2023.
Jacob VanLandingham is the Founder and President of Prevacus, Inc..
4 people are employed at Prevacus, Inc..
Prevacus, Inc. is based in Tallahassee, Florida.
The NAICS codes for Prevacus, Inc. are [3254, 32541, 325, 32].
The SIC codes for Prevacus, Inc. are [283, 28].